0001415889-24-019904.txt : 20240722 0001415889-24-019904.hdr.sgml : 20240722 20240722200442 ACCESSION NUMBER: 0001415889-24-019904 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240719 FILED AS OF DATE: 20240722 DATE AS OF CHANGE: 20240722 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOBMEIER ERIC CENTRAL INDEX KEY: 0001202785 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40475 FILM NUMBER: 241132684 MAIL ADDRESS: STREET 1: C/O SAETTLE GENETICS INC STREET 2: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Janux Therapeutics, Inc. CENTRAL INDEX KEY: 0001817713 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822289112 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10955 VISTA SORRENTO PARKWAY STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 751-4493 MAIL ADDRESS: STREET 1: 10955 VISTA SORRENTO PARKWAY STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 form4-07232024_120738.xml X0508 4 2024-07-19 0001817713 Janux Therapeutics, Inc. JANX 0001202785 DOBMEIER ERIC C/O JANUX THERAPEUTICS, INC. 10955 VISTA SORRENTO PARKWAY, SUITE 200 SAN DIEGO CA 92130 true false false false 0 Common Stock 2024-07-19 4 A 0 5000 0 A 5000 D Common Stock 2024-07-19 4 A 0 2500 0 A 7500 D Stock Option (Right to Buy) 44.68 2024-07-19 4 A 0 16700 0 A 2034-07-18 Common Stock 16700 16700 D Stock Option (Right to Buy) 44.68 2024-07-19 4 A 0 8350 0 A 2034-07-18 Common Stock 8350 8350 D Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in thirty-six equal monthly installments over a three year period, subject to the Reporting Person's continuous service on each such date. Represents the grant of RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on July 19, 2025, subject to the Reporting Person's continuous service on such date. The shares subject to the option will vest in thirty-six equal monthly installments over three years, subject to the Reporting Person's continuous service on each such date. The shares subject to the option will vest in twelve equal monthly installments over one year, subject to the Reporting Person's continuous service on each such date. /s/ Janes Pennington, Attorney-in-Fact 2024-07-22